{
    "medicine_id": "a5a05821ee77b777f2ea72898b35bb10eb6dfba0",
    "platform_id": "DB01218",
    "metadata": {
        "name": "Halfan 250 mg 1 Tablet",
        "composition": "250 mg 1 Halofantrine",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of Severe malaria",
            "contraindications": {
                "disease": "Side effects incldue coughing noisy rattling troubled breathing loss of appetite aches and pain in joints indigestion and skin itching or rash",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Halofantrine is a synthetic antimalarial which acts as a blood schizonticide It is effective against multi drug resistant including mefloquine resistant i P falciparum i malaria",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Halofantrine can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation ventricular arrhythmias torsade de pointes and convulsion can be increased when Quinine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation ventricular arrhythmias torsade de pointes and convulsion can be increased when Quinidine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The metabolism of Atomoxetine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The metabolism of Brexpiprazole can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The metabolism of Tetrabenazine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00516",
                        "description": "Bentoquatam can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Magnesium sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01575",
                        "description": "Kaolin can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "Zinc can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02165",
                        "description": "Zinc trihydroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04249",
                        "description": "Zinc Substituted Heme C can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06792",
                        "description": "Lanthanum carbonate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "Magaldrate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "Potassium alum can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Magnesium hydroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09221",
                        "description": "Polaprezinc can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Magnesium trisilicate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09321",
                        "description": "Zinc oxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09322",
                        "description": "Zinc sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Magnesium chloride can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Magnesium carbonate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11081",
                        "description": "Aluminum chloride can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "Magnesium citrate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "Zinc citrate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11175",
                        "description": "Zinc picolinate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11239",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11248",
                        "description": "Zinc gluconate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11306",
                        "description": "Bentonite can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "Aluminium acetoacetate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "Hydrotalcite can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13359",
                        "description": "Magnesium aspartate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "Magnesium peroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "Aluminium glycinate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "Aloglutamol can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13654",
                        "description": "Montmorillonite can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13749",
                        "description": "Magnesium gluconate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13786",
                        "description": "Magnesium orotate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14479",
                        "description": "Acetylcysteine zinc can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14485",
                        "description": "Zinc ascorbate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14487",
                        "description": "Zinc acetate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14493",
                        "description": "Zinc glycinate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "Magnesium can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14514",
                        "description": "Magnesium levulinate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14515",
                        "description": "Magnesium lactate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "Aluminium phosphate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14533",
                        "description": "Zinc chloride can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14548",
                        "description": "Zinc sulfate unspecified form can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14579",
                        "description": "Lanthanum III cation can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14532",
                        "description": "Zinc cation can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "Lumefantrine may increase the QTc prolonging activities of Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Thiethylperazine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Moricizine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The risk or severity of adverse effects can be increased when Halofantrine is combined with Dapsone"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Droperidol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Loperamide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Primaquine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Papaverine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Probucol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Azimilide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Technetium Tc 99m ciprofloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Telavancin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Antazoline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Fendiline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Eperisone is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Melperone is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Benidipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Entinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 101 is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Simendan is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Sultopride is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Otilonium is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Emedastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Fluvoxamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The metabolism of Amphetamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Nicotine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Cevimeline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The metabolism of Esmolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Bortezomib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The metabolism of Betaxolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The metabolism of Benzatropine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Lidocaine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Venlafaxine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Bupivacaine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Acetaminophen can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Gefitinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The metabolism of Codeine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Methadone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The metabolism of Olanzapine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Atenolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Diltiazem can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Chlorzoxazone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Clozapine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The metabolism of Mirtazapine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The metabolism of Palonosetron can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Mexiletine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Progesterone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The metabolism of Remoxipride can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Celecoxib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The metabolism of Oxycodone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The metabolism of Dextromethorphan can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The metabolism of Cinnarizine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The metabolism of Propranolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The metabolism of Lisuride can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Piperazine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Chloroquine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Dextropropoxyphene can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The metabolism of Galantamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Nicergoline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Amprenavir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Tamsulosin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Paroxetine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Nateglinide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The metabolism of Risperidone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The metabolism of Meclizine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The metabolism of Pentamidine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The metabolism of Dolasetron can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The metabolism of Minaprine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The metabolism of Donepezil can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The metabolism of Alprenolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The metabolism of Ondansetron can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Phenformin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Almotriptan can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Buprenorphine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The metabolism of Pindolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Azelastine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The metabolism of Formoterol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The metabolism of Methoxyflurane can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The metabolism of Tolterodine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Mequitazine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Perhexiline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The metabolism of Diphenhydramine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Tegaserod can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The metabolism of Sertraline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The metabolism of Chlorpheniramine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Nifedipine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The metabolism of Moclobemide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Propafenone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Dexfenfluramine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The metabolism of Oxymorphone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The metabolism of Acebutolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The metabolism of Nadolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The metabolism of Encainide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The metabolism of Lisdexamfetamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The metabolism of Arformoterol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Practolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The metabolism of Penbutolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The metabolism of Yohimbine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The metabolism of Tiotropium can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Antipyrine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The metabolism of Midomafetamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The metabolism of Ethylmorphine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The metabolism of 4 Methoxyamphetamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The metabolism of Dihydrocodeine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The metabolism of Dextroamphetamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The metabolism of Metamfetamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The metabolism of Oxprenolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Fusidic acid can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The metabolism of Lysergic acid diethylamide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The metabolism of Flunarizine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The metabolism of Celiprolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Nebivolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Lorcaserin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The metabolism of Dapoxetine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Clevidipine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The metabolism of Lofexidine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The metabolism of Rotigotine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The metabolism of Cariprazine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The metabolism of Sertindole can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The metabolism of Mianserin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Alogliptin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The metabolism of Tapentadol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The metabolism of Esmirtazapine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Vilazodone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The metabolism of Fesoterodine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Sparteine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Benzyl alcohol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Levomilnacipran can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Perospirone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The metabolism of Umeclidinium can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The metabolism of Opium can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Asunaprevir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The metabolism of Rupatadine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The metabolism of Talinolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The metabolism of Anisodamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The metabolism of Revefenacin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Rucaparib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The metabolism of Quetiapine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Ciclesonide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Labetalol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The metabolism of 5 methoxy N N dimethyltryptamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Nevirapine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Buspirone"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The metabolism of Eletriptan can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Zolpidem can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Darifenacin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Nefazodone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The metabolism of Doxepin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Mephenytoin"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Protriptyline"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The metabolism of Opipramol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The metabolism of Epinastine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The metabolism of Encorafenib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Citalopram is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Clemastine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Toremifene is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Imatinib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Trovafloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Cocaine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Escitalopram is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Domperidone is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Terfenadine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Cisapride is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Halofantrine can be increased when combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Halofantrine can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Halofantrine can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Nabilone"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Pioglitazone"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Loratadine"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Enzalutamide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Levothyroxine"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Trimethoprim"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Trametinib"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Halofantrine may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Pitolisant can be increased when it is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The serum concentration of the active metabolites of Deutetrabenazine can be increased when Deutetrabenazine is used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Halofantrine can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Boceprevir"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Safinamide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The metabolism of Gestodene can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Nabiximols can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Elbasvir"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Indinavir"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Halofantrine can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB11737",
                        "description": "The metabolism of Halofantrine can be increased when combined with Icotinib"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Halofantrine can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Halofantrine can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The metabolism of Halofantrine can be increased when combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Halofantrine can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The metabolism of Halofantrine can be increased when combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The metabolism of Halofantrine can be increased when combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Halofantrine can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Halofantrine can be increased when combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Halofantrine can be increased when combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Halofantrine can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Halofantrine can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Halofantrine can be increased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Halofantrine can be increased when combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Halofantrine can be increased when combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Halofantrine can be increased when combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Halofantrine can be increased when combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Halofantrine can be increased when combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Halofantrine can be increased when combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Halofantrine can be increased when combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Halofantrine can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Halofantrine can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Halofantrine can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Halofantrine can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Halofantrine can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Halofantrine can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Halofantrine can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Halofantrine can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Halofantrine can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Halofantrine can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Halofantrine can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Halofantrine can be increased when combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Halofantrine can be increased when combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Halofantrine can be increased when combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Dutasteride"
                    },
                    {
                        "drugbank-id": "DB04856",
                        "description": "The metabolism of Dexloxiglumide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Levonorgestrel"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Alprazolam"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Flutamide"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Testosterone"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Midazolam"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Tadalafil"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Praziquantel"
                    },
                    {
                        "drugbank-id": "DB01103",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Quinacrine"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Finasteride"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The metabolism of Telaprevir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The metabolism of Rivaroxaban can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The metabolism of Udenafil can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The metabolism of Saxagliptin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The metabolism of Ambrisentan can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "The metabolism of Cethromycin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06652",
                        "description": "The metabolism of Vicriviroc can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Ivacaftor can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The metabolism of Daclatasvir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The metabolism of Paritaprevir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The metabolism of Tezacaftor can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12301",
                        "description": "The metabolism of Doravirine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The metabolism of Hydrocortisone cypionate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The metabolism of Levamlodipine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The metabolism of Lemborexant can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Clindamycin"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Estrone"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The metabolism of Tacrolimus can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Temsirolimus can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Tamoxifen can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Trastuzumab emtansine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Clonidine"
                    },
                    {
                        "drugbank-id": "DB00205",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Pyrimethamine"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Ketoprofen"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Cabozantinib"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Montelukast"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Raloxifene"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Nilutamide"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Liotrix"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB01698",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Rutin"
                    },
                    {
                        "drugbank-id": "DB04216",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Quercetin"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Licofelone"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Vismodegib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB11632",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Opicapone"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Alpelisib"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The metabolism of Halofantrine can be increased when combined with Avatrombopag"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Halofantrine can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Halofantrine can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Halofantrine can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Halofantrine can be increased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Halofantrine can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Halofantrine can be increased when combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The metabolism of Halofantrine can be increased when combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The metabolism of Halofantrine can be increased when combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Halofantrine can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Hydrocortisone butyrate can be increased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14542",
                        "description": "The metabolism of Hydrocortisone phosphate can be increased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Paramethadione"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Mycophenolate mofetil"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Estradiol"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Naproxen"
                    },
                    {
                        "drugbank-id": "DB00799",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Tazarotene"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Repaglinide"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Ibuprofen"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Atorvastatin"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Tolbutamide"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Ketamine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The metabolism of Sitagliptin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The metabolism of Mestranol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The metabolism of Beraprost can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06510",
                        "description": "The metabolism of Muraglitazar can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The metabolism of Apixaban can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The metabolism of Odanacatib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The metabolism of Ketobemidone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Seratrodast can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The metabolism of R warfarin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The metabolism of Pitavastatin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "The metabolism of Riociguat can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Lobeglitazone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "The metabolism of Netoglitazone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "The metabolism of Rivoglitazone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "The metabolism of Ciglitazone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The metabolism of Ombitasvir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The metabolism of Selexipag can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The metabolism of Velpatasvir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The metabolism of Voxilaprevir can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Lorlatinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "The metabolism of Balaglitazone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Testosterone cypionate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Testosterone undecanoate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Estradiol acetate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Estradiol benzoate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Estradiol cypionate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Estradiol dienanthate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Estradiol valerate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The metabolism of S Warfarin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The metabolism of Dexibuprofen can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08502",
                        "description": "The metabolism of Capravirine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Ketorolac"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Anastrozole"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The metabolism of Apalutamide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The metabolism of Ozanimod can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The metabolism of Selumetinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pazopanib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Sotalol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Flecainide can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dacomitinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Theophylline"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Imipramine can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The therapeutic efficacy of Metharbital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The therapeutic efficacy of Riluzole can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The therapeutic efficacy of Phensuximide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The therapeutic efficacy of Progabide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The therapeutic efficacy of Phenacemide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The therapeutic efficacy of Delorazepam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The therapeutic efficacy of 7 Nitroindazole can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The therapeutic efficacy of Valpromide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The therapeutic efficacy of Deramciclane can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The therapeutic efficacy of Sulthiame can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The therapeutic efficacy of Beclamide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The therapeutic efficacy of Tiletamine can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The therapeutic efficacy of Brexanolone can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The therapeutic efficacy of Etiracetam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The therapeutic efficacy of Carisbamate can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The therapeutic efficacy of Pheneturide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The therapeutic efficacy of Neocitrullamon can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The therapeutic efficacy of Medazepam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The therapeutic efficacy of Phenibut can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The therapeutic efficacy of Ethadione can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The therapeutic efficacy of Cannabidivarin can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The therapeutic efficacy of JNJ 26489112 can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The therapeutic efficacy of Gabapentin can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The therapeutic efficacy of Halofantrine can be decreased when used in combination with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The therapeutic efficacy of Halofantrine can be decreased when used in combination with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The therapeutic efficacy of Perampanel can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The therapeutic efficacy of Lorazepam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The therapeutic efficacy of Butalbital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The therapeutic efficacy of Topiramate can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The therapeutic efficacy of Clobazam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The therapeutic efficacy of Methohexital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The therapeutic efficacy of Thiopental can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The therapeutic efficacy of Clorazepic acid can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The therapeutic efficacy of Ethotoin can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The therapeutic efficacy of Primidone can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The therapeutic efficacy of Tiagabine can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The therapeutic efficacy of Clonazepam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The therapeutic efficacy of Thiamylal can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The therapeutic efficacy of Estazolam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The therapeutic efficacy of Amobarbital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The therapeutic efficacy of Barbital can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The therapeutic efficacy of Rufinamide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The therapeutic efficacy of Lacosamide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The therapeutic efficacy of Remacemide can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The therapeutic efficacy of Stiripentol can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The therapeutic efficacy of Eslicarbazepine acetate can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The therapeutic efficacy of Doramectin can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of seizure can be increased when Halofantrine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Halofantrine can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Halofantrine can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Halofantrine can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Halofantrine can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Halofantrine can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Halofantrine can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Halofantrine can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Halofantrine can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Halofantrine can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Halofantrine can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Halofantrine can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Halofantrine can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Halofantrine can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Halofantrine can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Halofantrine can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Amitriptyline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The metabolism of Timolol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "The risk or severity of seizure can be increased when Halofantrine is combined with Dalfampridine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Halofantrine may increase the QTc prolonging activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of seizure can be increased when Bupropion is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Halofantrine can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The metabolism of Hydrocodone can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Halofantrine can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Halofantrine can be increased when it is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Halofantrine can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The serum concentration of Oliceridine can be increased when it is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Halofantrine can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}